📡 Signal Thesis
Robotics signal velocity has accelerated sharply, with 30-day mentions (129) already exceeding the prior 90-day baseline (91)—a roughly 4x run-rate increase that points to intensifying activity around humanoid platforms, surgical automation, and embodied AI integration. The positive article sentiment, juxtaposed against drawdowns in incumbent names like ISRG (-16.2%) and NNDM (-11.2%), suggests the narrative momentum is outpacing near-term operator fundamentals, with capital and attention rotating toward next-generation foundation-model-driven robotics rather than
📊 Signal Evidence
129
Signals last 30 days
91
Signals last 90 days
4.3x
Current vs 90-day avg rate
Positive (+0.30)
Article sentiment
🏢 Top Companies & Domain Index
👁️
Showcase mode.
Company pages marked Premium will require a paid subscription when the platform launches. Full intelligence is visible now.
FSI Robotics Index
▼ 13.7%
Average 90-day return across top 2 tracked companies
ISRG -16.2% · NNDM -11.2%
| Ticker | Price | 30-Day Return | 90-Day Return |
|---|---|---|---|
| ISRG#1 | $424.64 | -6.4% | -16.2% |
| ABB | — | N/A | N/A |
| IRBT Premium | — | N/A | N/A |
| NNDM#2 Premium | $1.75 | +4.8% | -11.2% |
Companies identified by FSI signal pipeline as operating in this domain. Not a recommendation to buy or sell.
🔬 Technology Intelligence Brief
Fundamental Research
Applied Research
Early Commercial
Scaling
Mature
Recent Breakthroughs
Foundation models for robotics (e.g., Physical Intelligence's π0, Google DeepMind's RT-2/Gemini Robotics, Figure's Helix) are enabling generalist manipulation policies that transfer across embodiments with minimal fine-tuning. Humanoid platforms from Figure, 1X, Agility, Unitree, and Tesla Optimus have moved from lab demos into paid pilots at BMW, Mercedes, GXO, and Amazon, while teleoperation-driven data collection pipelines are scaling rapidly. Component costs (actuators, lidar, GPUs at the edge) continue to decline, expanding the addressable design space.
12–24 Month Milestones to Watch
Watch for the first multi-thousand-unit humanoid commercial deployments in logistics and automotive in 2025-2026, alongside published throughput and uptime metrics that can be benchmarked against human labor costs. Key technical markers include demonstrated zero-shot generalization on novel manipulation tasks, sub-$30K bill-of-materials humanoid pricing, and surgical robotics share gains from new entrants (Medtronic Hugo, J&J Ottava) challenging Intuitive's dominance.
🚀 Accelerators
A clear ROI case study showing 18-24 month payback on humanoid deployment in a labor-constrained vertical, combined with breakthrough in cross-embodiment foundation models that collapse data requirements, would compress adoption timelines dramatically.
⚠️ What Could Stall It
Safety incidents in human-shared workspaces triggering restrictive regulation, or persistent failure of foundation models to handle long-horizon dexterous tasks reliably, could push general-purpose robotics back into an extended capability trough despite strong capital inflows.
Not investment advice. This scorecard is general signal intelligence derived from publicly available data. It does not constitute personalised investment advice or a recommendation to buy, sell, or hold any security. Past signal momentum does not guarantee future price performance. Capital at risk.